A new fund allows investors to finance late-stage global health technologies in low-income countries, MarketWatch reports. The Global Health Investment Fund was launched by J.P. Morgan Chase & Co. in partnership with the Bill & Melinda Gates Foundation. The fund has secured $94 million from investors to fight HIV/AIDS, malaria and tuberculosis, as well as maternal and infant mortality. The fund will invest in new drugs and vaccines, emerging diagnostic tools, child-friendly formulations of existing products and the expansion of manufacturing capacity. Fund investors include GlaxoSmithKline, Merck & Co., the Pfizer Foundation and others.

To read the article, click here.